` PHR (Pharmena SA) vs WIG20 Comparison - Alpha Spread

P
PHR
vs
W
WIG20

Over the past 12 months, PHR has underperformed WIG20, delivering a return of -2% compared to the WIG20's +48% growth.

Stocks Performance
PHR vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PHR vs WIG20

Performance Gap Between PHR and WIG20
HIDDEN
Show

Performance By Year
PHR vs WIG20

Loading
PHR
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Pharmena SA vs Peers

WIG20
PHR
OR
ULVR
HINDUNILVR
HLN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Pharmena SA
Glance View

Market Cap
45.7m PLN
Industry
Consumer products

PHARMENA SA engages in developing and marketing products based on a patented, physiological, and natural active substance 1-MNA. The company is headquartered in Lodz, Woj. Lodzkie and currently employs 24 full-time employees. The company went IPO on 2008-08-25. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

PHR Intrinsic Value
HIDDEN
Show
Back to Top